These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6409409)

  • 1. Decreased vulnerability to ventricular fibrillation by vasodilator-induced baroreceptor sensitisation.
    Kowey PR; Verrier RL; Lown B
    Cardiovasc Res; 1983 Feb; 17(2):106-12. PubMed ID: 6409409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart.
    Kowey PR; Verrier RL; Lown B
    Am Heart J; 1983 Mar; 105(3):366-71. PubMed ID: 6187202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential vasodilator effect of nitroglycerin on systemic capacitance and resistance vessels in anesthetized dogs, and the mechanism of its action--a study by measuring mean circulatory pressure and total peripheral resistance.
    Nagata K; Ito H; Minatoguchi S; Hirose I; Sahashi T; Wada H; Takai K; Watanabe I; Hirakawa S
    Jpn Circ J; 1989 Nov; 53(11):1371-81. PubMed ID: 2516138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect of prostaglandin E1, but not prostacyclin, on ouabain-induced ventricular fibrillation in guinea-pigs.
    Nakanishi H; Ono T; Shirasaka M; Yoshida H
    Fukushima J Med Sci; 1992 Dec; 38(2):105-10. PubMed ID: 1308477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalis drugs and vulnerability to ventricular fibrillation.
    Brooks WW; Verrier RL; Lown B
    Eur J Pharmacol; 1979 Jul; 57(1):69-78. PubMed ID: 38976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin and noradrenaline on discharge in fibres of the cervical sympathetic nerve in cats and dogs.
    Morrison JF; Pickford M
    Br J Pharmacol; 1971 Apr; 41(4):674-82. PubMed ID: 4325451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of vagus nerve stimulation on catecholamine-halothane-induced ventricular fibrillation in dogs.
    Waxman MB; Sharma AD; Asta J; Cameron DA; Wald RW
    Can J Physiol Pharmacol; 1989 Jul; 67(7):801-9. PubMed ID: 2766111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a new technique--blood pressure clamping--for analysis of prostaglandin interference with sympathetic neurotransmission in man.
    Wennmalm A
    Acta Physiol Scand; 1989 May; 136(1):89-96. PubMed ID: 2773665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure-independent inhibition of sympathetic activity by noradrenaline: role of baroreceptor C fibres.
    Akre S; Aars H
    Acta Physiol Scand; 1977 Jul; 100(3):303-8. PubMed ID: 920201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitroglycerin on ventricular fibrillation threshold of nonischemic myocardium.
    Dashkoff N; Roland JM; Varghese PJ; Pitt B
    Am J Cardiol; 1976 Aug; 38(2):184-8. PubMed ID: 821329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostacyclin on vascular capacity in the dog.
    Fulghum TG; DiMarco JP; Supple EW; Nash I; Gendlerman J; Eton DF; Newell JB; Zusman RM; Powell WJ
    J Clin Invest; 1985 Sep; 76(3):999-1006. PubMed ID: 3930573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrillatory effects of renal denervation on ventricular fibrillation in a canine model of pacing-induced heart failure.
    Luo Q; Jin Q; Zhang N; Huang S; Han Y; Lin C; Ling T; Chen K; Pan W; Wu L
    Exp Physiol; 2018 Jan; 103(1):19-30. PubMed ID: 29094471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of the opioids fentanyl and buprenorphine on ventricular vulnerability during acute coronary artery occlusion.
    Saini V; Carr DB; Verrier RL
    Cardiovasc Res; 1989 Dec; 23(12):1001-6. PubMed ID: 2559806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baroreceptor denervation on the inhibition of renin release by vasopressin.
    Gregory LC; Quillen EW; Keil LC; Reid IA
    Endocrinology; 1988 Jul; 123(1):319-27. PubMed ID: 3289894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The altered baroreceptor response to nitroglycerin in congestive heart failure.
    Faxon DP; Gross S; Tilney C; Ryan TJ
    Clin Cardiol; 1980; 3(1):7-13. PubMed ID: 6769628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.